Dr Reuben Benjamin

Dr Benjamin is a Clinical Senior Lecturer at King’s College London and Honorary Consultant Haematologist at King’s College Hospital with a specialist interest in multiple myeloma and CAR-T cell therapy for haematological malignancies and autoimmune disease. He is the academic lead of the CAR-T cell programme at King’s College Hospital, London and runs a research group at King’s College London focused on investigating mechanisms of resistance to CAR-T cells, developing next generation CAR-T cells targeting cancer and autoimmune disease as well as exploring the biology of multiple myeloma. He was Chief Investigator of the CALM Trial, the first allogeneic CAR-T cell trial of its kind for B-ALL and is Principal Investigator of a number of multiple myeloma CAR-T cell trials. He is currently setting up point-of-care CAR-T manufacturing at King’s to support in-house academic CAR-T cell trials.